Diagnosis, prevalence, and risk factors of atrophic gastritis
- Authors: Tsukanov V.1, Vasyutin A.1, Tonkikh Y.1, Peretyatko O.1
-
Affiliations:
- Research Institute of Medical Problems of the North, Krasnoyarsk Research Center, Siberian Branch, Russian Academy of Sciences
- Issue: Vol 29, No 10 (2018)
- Pages: 8-11
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/117292
- DOI: https://doi.org/10.29296/25877305-2018-10-02
- ID: 117292
Cite item
Abstract
Full Text
About the authors
V. Tsukanov
Research Institute of Medical Problems of the North, Krasnoyarsk Research Center, Siberian Branch, Russian Academy of Sciences
Email: gastro@impn.ru
Professor, MD Krasnoyarsk
A. Vasyutin
Research Institute of Medical Problems of the North, Krasnoyarsk Research Center, Siberian Branch, Russian Academy of Sciences
Email: gastro@impn.ru
Candidate of Medical Sciences Krasnoyarsk
Yu. Tonkikh
Research Institute of Medical Problems of the North, Krasnoyarsk Research Center, Siberian Branch, Russian Academy of Sciences
Email: gastro@impn.ru
Candidate of Medical Sciences Krasnoyarsk
O. Peretyatko
Research Institute of Medical Problems of the North, Krasnoyarsk Research Center, Siberian Branch, Russian Academy of Sciences
Email: gastro@impn.ru
Candidate of Medical Sciences Krasnoyarsk
References
- Malfertheiner P., Chan F., McColl K. Peptic ulcer disease // Lancet. - 2009; 374 (9699): 1449-61. doi: 10.1016/S0140-6736(09)60938-7.
- Graham D. Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits // Gastroenterology. - 2015; 148 (4): 719-31. DOI: 10.1053/j. gastro.2015.01.040.
- Sugano K., Tack J., Kuipers E. et al. Kyoto global consensus report on Helicobacter pylori gastritis // Gut. - 2015; 64 (9): 1353-67. DOI: 10.1136/ gutjnl-2015-309252.
- Malfertheiner P., Megraud F., O'Morain C. et al. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report // Gut. - 2017; 66 (1): 6-30. doi: 10.1136/gutjnl- 2016-312288.
- Rugge M., Genta R., Graham D. et al. Chronicles of a cancer foretold: 35 years of gastric cancer risk assessment // Gut. - 2016; 65 (5): 721-5. DOI: 10.1136/ gutjnl-2015-310846.
- Misiewicz J. The Sydney System: a new classification of gastritis. Introduction // J. Gastroenterol. Hepatol. - 1991; 6 (3): 207-8.
- Dixon M., Genta R., Yardley J. et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994 // Am. J. Surg. Pathol. - 1996; 20 (10): 1161-81.
- Rugge M., Correa P., Di Mario F. et al. OLGA staging for gastritis: a tutorial // Dig. Liver Dis. - 2008; 40 (8): 650-8. doi: 10.1016/j.dld.2008.02.030.
- Dinis-Ribeiro M., Areia M., de Vries A. et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED) // Endoscopy. - 2012; 44 (1): 74-94. doi: 10.1055/s-0031-1291491.
- Liu Y., Ponsioen C., Waverling G. et al. Helicobacter pylori gastritis - a global view. In: Hunt R.H., Tytgat G.N.J. (eds) Helicobacter pylori / Dordrecht: Kluwer academic publishers, 2000; p. 213-20. doi: 10.1007/978-94-011-3927-4_23.
- Штыгашева О.В., Цуканов В.В. Ассоциация CаgA и VacA штаммов Helicobacter pylori и язвенной болезни в организованной популяции г. Абакана // Рос. журн. гастроэнтерол., гепатол., колопроктол. - 2004; 14 (2): 84-7.
- Агеева Е.С., Штыгашева О.В., Рязанцева Н.В. и др. Молекулярно-генетические факторы, влияющие на исход инфицирования Helicobacter pylori у жителей Республики Хакасия // Рос. журн. гастроэнтерол., гепатол., колопроктол. - 2010; 20 (4): 16-21.
- Lombardo L., Leto R., Molinaro G. et al. Prevalence of atrophic gastritis in dyspeptic patients in Piedmont. A survey using the GastroPanel test // Clin. Chem. Lab. Med. - 2010; 48 (9): 1327-32. doi: 10.1515/CCLM.2010.256.
- Leja M., Cine E., Rudzite D. et al. Prevalence of Helicobacter pylori infection and atrophic gastritis in Latvia // Eur. J. Gastroenterol. Hepatol. - 2012; 24(12): 1410-7. doi: 10.1097/MEG.0b013e3283583ca5.
- Telaranta-Keerie A., Kara R., Paloheimo L. et al. Prevalence of undiagnosed advanced atrophic corpus gastritis in Finland: an observational study among 4,256 volunteers without specific complaints // Scand. J. Gastroenterol. - 2010; 45 (9): 1036-41. doi: 10.3109/00365521.2010.487918.
- Benberin V., Bektayeva R., Karabayeva R. et al. Prevalence of H. pylori infection and atrophic gastritis among symptomatic and dyspeptic adults in Kazakhstan. A hospital-based screening study using a panel of serum biomarkers // Anticancer Res. - 2013; 33 (10): 4595-602.
- Toyoda K., Furusyo N., Ihara T. et al. Serum pepsinogen and Helicobacter pylori infection - a Japanese population study // Eur. J. Clin. Microbiol. Infect. Dis. - 2012; 31 (9): 2117-24. doi: 10.1007/s10096-011-1543-0.
- Zou D., He J., Ma X. et al. Helicobacter pylori infection and gastritis: the Systematic Investigation of gastrointestinaL diseases in China (SILC) // J. Gastroenterol. Hepatol. - 2011; 26 (5): 908-15. doi: 10.1111/j.1440-1746.2010.06608.x.
- Цуканов В.В., Третьякова О.В., Амельчугова О.С. и др. Распространенность атрофического гастрита тела желудка у населения г. Красноярска старше 45 лет // Рос. журн. гастроэнтерол., гепатол., колопроктол. - 2012; 22 (4): 27-31.
- Решетников О.В., Курилович С.А., Кротов С.А. и др. Распространенность атрофического гастрита в разных популяциях Сибири по данным серологического исследования // Клин. медицина. - 2008; 86 (7): 35-8.
- Леонтьева Н.И. Грачева Н.М., Новикова Л.И. Клиническая оценка диагностики хеликобактериоза у больных с хронической патологией желудочнокишечного тракта диагностической тест-системой «Гастропанель» // Эксперим. и клинич. гастроэнтерол. - 2009; (2, прил. 1): 80.
- Roman L., Lukyanchuk R., Sablin O. et al. Prevalence of H. pylori Infection and Atrophic Gastritis in a Population-based Screening with Serum Biomarker Panel (GastroPanel®) in St. Petersburg // Anticancer Res. - 2016; 36 (8): 412938.
- Song J., Kim Y., Heo N. et al. High Salt Intake Is Associated with Atrophic Gastritis with Intestinal Metaplasia // Cancer Epidemiol. Biomarkers Prev. - 2017; 26 (7): 1133-8. doi: 10.1158/1055-9965.EPI-16-1024.
- Graham D. Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits // Gastroenterology. - 2015; 148 (4): 719-31. DOI: 10.1053/j. gastro.2015.01.040.
- Fuccio L., Zagari R., Eusebi L. et al. Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? // Ann. Intern. Med. -2009; 151 (2): 121-8. doi: 10.7326/0003-4819-151-2-200907210-00009.
- Wang J., Xu L., Shi R. et al. Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication: a meta-analysis // Digestion. - 2011; 83 (4): 253-60. doi: 10.1159/000280318.
- Lee Y., Chen T., Chiu H. et al. The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention // Gut. -2013; 62 (5): 676-82. doi: 10.1136/gutjnl-2012-302240.
- Lee Y., Chiang T., Chou C. et al. Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis // Gastroenterology. - 2016; 150 (5): 1113-24. DOI: 10.1053/j. gastro.2016.01.028.
- Malfertheiner P., Megraud F., O'Morain C. et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report // Gut. - 2007; 56 (6): 772-81. doi: 10.1136/gut.2006.101634.
- Цуканов В.В., Амельчугова О.С., Каспаров Э.В. и др. Роль эрадикации Helicobacter pylori в профилактике рака желудка // Тер. арх. - 2014; 86 (8): 124-7.